Cargando…

Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells

BACKGROUND: The mechanisms during the initial phase of oxygen toxicity leading to pulmonary tissue damage are incompletely known. Increase of tumour necrosis factor alpha (TNFalpha) represents one of the first pulmonary responses to hyperoxia. We hypothesised that, in the initial phase of hyperoxia,...

Descripción completa

Detalles Bibliográficos
Autores principales: Guthmann, Florian, Wissel, Heide, Schachtrup, Christian, Tölle, Angelika, Rüdiger, Mario, Spener, Friedrich, Rüstow, Bernd
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548140/
https://www.ncbi.nlm.nih.gov/pubmed/15663790
http://dx.doi.org/10.1186/1465-9921-6-10
_version_ 1782122323509248000
author Guthmann, Florian
Wissel, Heide
Schachtrup, Christian
Tölle, Angelika
Rüdiger, Mario
Spener, Friedrich
Rüstow, Bernd
author_facet Guthmann, Florian
Wissel, Heide
Schachtrup, Christian
Tölle, Angelika
Rüdiger, Mario
Spener, Friedrich
Rüstow, Bernd
author_sort Guthmann, Florian
collection PubMed
description BACKGROUND: The mechanisms during the initial phase of oxygen toxicity leading to pulmonary tissue damage are incompletely known. Increase of tumour necrosis factor alpha (TNFalpha) represents one of the first pulmonary responses to hyperoxia. We hypothesised that, in the initial phase of hyperoxia, TNFalpha activates the caspase cascade in type II pneumocytes (TIIcells). METHODS: Lung sections or freshly isolated TIIcells of control and hyperoxic treated rats (48 hrs) were used for the determination of TNFalpha (ELISA), TNF-receptor 1 (Western blot) and activity of caspases 8, 3, and 9 (colorimetrically). NF-kappaB activation was determined by EMSA, by increase of the p65 subunit in the nuclear fraction, and by immunocytochemistry using a monoclonal anti-NF-kappaB-antibody which selectively stained the activated, nuclear form of NF-kappa B. Apoptotic markers in lung tissue sections (TUNEL) and in TIIcells (cell death detection ELISA, Bax, Bcl-2, mitochondrial membrane potential, and late and early apoptotic cells) were measured using commercially available kits. RESULTS: In vivo, hyperoxia activated NF-kappaB and increased the expression of TNFalpha, TNF-receptor 1 and the activity of caspase 8 and 3 in freshly isolated TIIcells. Intratracheal application of anti-TNFalpha antibodies prevented the increase of TNFRI and of caspase 3 activity. Under hyperoxia, there was neither a significant change of cytosolic cytochrome C or of caspase 9 activity, nor an increase in apoptosis of TIIcells. Hyperoxia-induced activation of caspase 3 gradually decreased over two days of normoxia without increasing apoptosis. Therefore, activation of caspase 3 is a temporary effect in sublethal hyperoxia and did not mark the "point of no return" in TIIcells. CONCLUSION: In the initiation phase of pulmonary oxygen toxicity, an increase of TNFalpha and its receptor TNFR1 leads to the activation of caspase 8 and 3 in TIIcells. Together with the hyperoxic induced increase of Bax and the decrease of the mitochondrial membrane potential, activation of caspase 3 can be seen as sensitisation for apoptosis. Eliminating the TNFalpha effect in vivo by anti-TNFalpha antibodies prevents the pro-apoptotic sensitisation of TIIcells.
format Text
id pubmed-548140
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5481402005-02-05 Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells Guthmann, Florian Wissel, Heide Schachtrup, Christian Tölle, Angelika Rüdiger, Mario Spener, Friedrich Rüstow, Bernd Respir Res Research BACKGROUND: The mechanisms during the initial phase of oxygen toxicity leading to pulmonary tissue damage are incompletely known. Increase of tumour necrosis factor alpha (TNFalpha) represents one of the first pulmonary responses to hyperoxia. We hypothesised that, in the initial phase of hyperoxia, TNFalpha activates the caspase cascade in type II pneumocytes (TIIcells). METHODS: Lung sections or freshly isolated TIIcells of control and hyperoxic treated rats (48 hrs) were used for the determination of TNFalpha (ELISA), TNF-receptor 1 (Western blot) and activity of caspases 8, 3, and 9 (colorimetrically). NF-kappaB activation was determined by EMSA, by increase of the p65 subunit in the nuclear fraction, and by immunocytochemistry using a monoclonal anti-NF-kappaB-antibody which selectively stained the activated, nuclear form of NF-kappa B. Apoptotic markers in lung tissue sections (TUNEL) and in TIIcells (cell death detection ELISA, Bax, Bcl-2, mitochondrial membrane potential, and late and early apoptotic cells) were measured using commercially available kits. RESULTS: In vivo, hyperoxia activated NF-kappaB and increased the expression of TNFalpha, TNF-receptor 1 and the activity of caspase 8 and 3 in freshly isolated TIIcells. Intratracheal application of anti-TNFalpha antibodies prevented the increase of TNFRI and of caspase 3 activity. Under hyperoxia, there was neither a significant change of cytosolic cytochrome C or of caspase 9 activity, nor an increase in apoptosis of TIIcells. Hyperoxia-induced activation of caspase 3 gradually decreased over two days of normoxia without increasing apoptosis. Therefore, activation of caspase 3 is a temporary effect in sublethal hyperoxia and did not mark the "point of no return" in TIIcells. CONCLUSION: In the initiation phase of pulmonary oxygen toxicity, an increase of TNFalpha and its receptor TNFR1 leads to the activation of caspase 8 and 3 in TIIcells. Together with the hyperoxic induced increase of Bax and the decrease of the mitochondrial membrane potential, activation of caspase 3 can be seen as sensitisation for apoptosis. Eliminating the TNFalpha effect in vivo by anti-TNFalpha antibodies prevents the pro-apoptotic sensitisation of TIIcells. BioMed Central 2005 2005-01-21 /pmc/articles/PMC548140/ /pubmed/15663790 http://dx.doi.org/10.1186/1465-9921-6-10 Text en Copyright © 2005 Guthmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Guthmann, Florian
Wissel, Heide
Schachtrup, Christian
Tölle, Angelika
Rüdiger, Mario
Spener, Friedrich
Rüstow, Bernd
Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells
title Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells
title_full Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells
title_fullStr Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells
title_full_unstemmed Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells
title_short Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells
title_sort inhibition of tnfalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type ii cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548140/
https://www.ncbi.nlm.nih.gov/pubmed/15663790
http://dx.doi.org/10.1186/1465-9921-6-10
work_keys_str_mv AT guthmannflorian inhibitionoftnfalphainvivopreventshyperoxiamediatedactivationofcaspase3intypeiicells
AT wisselheide inhibitionoftnfalphainvivopreventshyperoxiamediatedactivationofcaspase3intypeiicells
AT schachtrupchristian inhibitionoftnfalphainvivopreventshyperoxiamediatedactivationofcaspase3intypeiicells
AT tolleangelika inhibitionoftnfalphainvivopreventshyperoxiamediatedactivationofcaspase3intypeiicells
AT rudigermario inhibitionoftnfalphainvivopreventshyperoxiamediatedactivationofcaspase3intypeiicells
AT spenerfriedrich inhibitionoftnfalphainvivopreventshyperoxiamediatedactivationofcaspase3intypeiicells
AT rustowbernd inhibitionoftnfalphainvivopreventshyperoxiamediatedactivationofcaspase3intypeiicells